XOMA Royalty (XOMA) EPS (Weighted Average and Diluted) (2010 - 2026)

XOMA Royalty's (XOMA) quarterly EPS (Weighted Average and Diluted) came in at $0.17 in Q1 2026, up 183.33% year-on-year from $0.06 in Q1 2025, and down 34.62% quarter-over-quarter from $0.26 in Q4 2025.

XOMA Royalty (XOMA) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed EPS (Weighted Average and Diluted) across 17 years of filings, most recently posting $0.17 for Q1 2026.

  • EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.17, up 183.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.57 (up 237.72% YoY), and the FY2025 annual result was $1.46, up 188.48% from the prior year.
  • EPS (Weighted Average and Diluted) came in at $0.17 for Q1 2026 at XOMA Royalty, down from $0.26 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.84 in Q2 2024 to a low of -$1.87 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.48 (2022), against an average of -$0.38.
  • Across the five-year window, EPS (Weighted Average and Diluted) slumped 206.25% in 2023 and soared 242.37% in 2024, its largest moves.
  • XOMA Royalty's EPS (Weighted Average and Diluted) stood at -$0.64 in 2022, then tumbled by 192.19% to -$1.87 in 2023, then soared by 75.94% to -$0.45 in 2024, then surged by 157.78% to $0.26 in 2025, then tumbled by 34.62% to $0.17 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at $0.17 (Q1 2026), $0.26 (Q4 2025), and $0.7 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 0.68
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 3.06
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 3,086.42
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 0.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 0.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 4.02
9 Abivax 95.45 Bn 95.45 Bn - -0.61
10 XOMA Royalty 5.52 Mn -60.56 Mn - 0.17

Historic Data

Download Data
DateValue
Mar 31, 2026 0.17
Dec 31, 2025 0.26
Sep 30, 2025 0.70
Jun 30, 2025 0.44
Mar 31, 2025 0.06
Dec 31, 2024 -0.45
Sep 30, 2024 -1.59
Jun 30, 2024 0.84
Mar 31, 2024 -0.86
Dec 31, 2023 -1.87
Sep 30, 2023 -0.60
Jun 30, 2023 -0.59
Mar 31, 2023 -0.98
Dec 31, 2022 -0.64
Sep 30, 2022 -0.48
Jun 30, 2022 -0.53
Mar 31, 2022 -0.32
Dec 31, 2021 2.18
Sep 30, 2021 -0.51
Jun 30, 2021 -0.31